Kevin B. Knopf, M.D., M.P.H., Scientist; Medical Oncologist and Hematologist at CPMC

California Pacific CURRENTS: The online journal of CPMC Research Institute

Improving the treatment of solid tumors and hematological malignancies

Research Overview

  • Dr. Knopf specializes in the treatment of hematological malignancies, and cancers of the colon, rectum, lung, and prostate.
  • He lectures internationally on challenges and advances in the treatment of cancer.
  • Dr. Knopf investigates the efficacy and safety of new therapies for chronic lymphocytic leukemia, non-Hodgkin’s lymphoma, lung cancer, and colorectal cancer.
  • He is a reviewer for the Journal of Supportive Oncology and the Journal of Clinical Oncology

Training
 

Dr. Knopf obtained his M.D. from the University of California, San Francisco School of Medicine. He completed residencies in internal medicine and radiation oncology at Memorial Sloan Kettering Cancer Center in New York, and fellowships in medicine and health services and economics at the National Institutes of Health in Bethesda, Maryland.


 

Publication Search

Publications

Noxon V, Knopf KB, Norris LB, Chen B, Yang YT, Qureshi ZP, Hrushesky W, Lebby AA, Schooley B, Hikmet N, Dickson M, Thamer M, Cotter D, Yarnold PR, Bennett CL, Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract

Divino V, Karve S, Gaughan A, DeKoven M, Gao G, Knopf KB, Lanasa MC, Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis. J Comp Eff Res

Knopf KB, Divino V, McGarry L, Chen YJ, Pokras S, Munakata J, Taylor C, Ng D, Nieset C, Huang H, Economic Burden of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia. Clin Lymphoma Myeloma Leuk

Hermanson TT, Hrushesky WJ, Knopf KB, Bennett CL, Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract

Knopf KB, Duh MS, Lafeuille MH, Gravel J, Lefebvre P, Niculescu L, Ba-Mancini A, Ma E, Shi H, Comenzo RL, Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma. Clin Lymphoma Myeloma Leuk

AVBCC 2013 Steering Committee: Co-Chairs., Zweigenhaft B, Bosserman L, Kenney JT Jr, Lawless GD, Marsland TA, Deligdish CK, Burgoyne DS, Knopf KB, Long DM, McKercher P, Owens GM, Hennessy JE, Lang JR, Malin J, Natelson L, Palmgren MC, Slotnik J, Shockney LD, Vogenberg FR, Defining Value in Cancer Care: AVBCC 2013 Steering Committee Report. Am Health Drug Benefits

VIEW ALL
Kevin B. Knopf, M.D., M.P.H., Scientist; Medical Oncologist and Hematologist at CPMC
Primary Research Interests
  • New therapies for the treatment of solid tumors and hematological malignancies